Skip to main content

Table 3 Comparison of strain by CMR-FT between anthracycline and control groups

From: Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines

Variable Anthracycline (n = 18) Control (n = 17) p value
LV-GCS (%) − 14.8 ± 2.8 − 16.7 ± 2.1 0.026
LV-GCSR-S (%/s) − 83.0 ± 18.0 − 88.3 ± 14.0 0.333
LV-GCSR-E (%/s) 53.5 ± 19.3 72.2 ± 26.7 0.022
LV-GCSR-A (%/s) 50.2 ± 19.2 54.4 ± 24.5 0.579
LV-GLS (%) − 12.1 ± 2.9 − 14.1 ± 2.0 0.025
LV-GLSR-S (%/s) − 61.2 ± 14.1 − 67.2 ± 11.4 0.179
LV-GLSR-E (%/s) 40.4 ± 13.0 55.9 ± 17.8 0.006
LV-GLSR-A (%/s) 41.9 ± 14.4 47.5 ± 15.7 0.282
LV-GRS (%) 27.3 ± 7.5 30.3 ± 5.2 0.184
LV-GRSR-S (%/s) 120.2 ± 31.4 129.8 ± 22.4 0.300
LV-GRSR-E (%/s) − 114.4 ± 37.1 − 170.5 ± 48.0  < 0.001
LV-GRSR-A (%/s) − 86.6 ± 51.0 − 80.3 ± 41.3 0.692
RV-GLS (%) − 14.2 ± 3.7 − 15.4 ± 3.6 0.326
RV-GLSR-S (%/s) − 70.5 ± 20.6 − 81.7 ± 23.9 0.147
RV-GLSR-E (%/s) 45.1 ± 20.1 56.0 ± 15.7 0.083
RV-GLSR-A (%/s) 59.9 ± 25.6 57.1 ± 24.5 0.736
  1. Data expressed as mean ± standard deviation (SD)
  2. GCS global circumferential strain, GCSR-S global circumferential systolic strain rate, GCSR-E global circumferential early diastolic strain rate, GCSR-A global circumferential late diastolic strain rate, GLS global longitudinal strain, GLSR-S global longitudinal systolic strain rate, GLSR-E global longitudinal early diastolic strain rate, GLSR-A global longitudinal late diastolic strain rate, GRS global radial strain, GRSR-S global radial systolic strain rate, GRSR-E global radial early diastolic strain rate, GRSR-A global radial late diastolic strain rate, LV left ventricular, RV right ventricular